Page last updated: 2024-08-23

amonafide and chlorambucil

amonafide has been researched along with chlorambucil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flanagan, JU; Kemp, CA; Maréchal, JD; Paine, MJ; Roberts, GC; Sutcliffe, MJ; van Eldik, AJ; Wolf, CR1
Ben-David, G; Firer, MA; Gancz, A; Gellerman, G; Gilad, Y; Luboshits, G; Minnes, R; Senderowitz, H; Tuchinsky, H1
Bazylevich, A; Gellerman, G; Hershkovitz-Rokah, O; Patsenker, L; Shpilberg, O; Tuchinsky, H; Weissman, R; Zigman-Hoffman, E1

Other Studies

3 other study(ies) available for amonafide and chlorambucil

ArticleYear
Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
    Journal of medicinal chemistry, 2004, Oct-21, Volume: 47, Issue:22

    Topics: Binding Sites; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Factual; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship

2004
Discovery of potent molecular chimera (CM358) to treat human metastatic melanoma.
    European journal of medicinal chemistry, 2017, Sep-29, Volume: 138

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Heterocyclic Compounds, 3-Ring; Humans; Melanoma; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Pyrimidinones; Structure-Activity Relationship; Topoisomerase II Inhibitors

2017
Synthesis and Biological Studies of New Multifunctional Curcumin Platforms for Anticancer Drug Delivery.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2019, Volume: 15, Issue:5

    Topics: Adenine; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Chlorambucil; Curcumin; Drug Carriers; Drug Liberation; Humans; Naphthalimides; Organophosphonates; Phosphorylation; Prodrugs; Transcription Factor RelA

2019